###begin article-title 0
Lactate Dehydrogenase-Elevating Virus Induces Systemic Lymphocyte Activation via TLR7-Dependent IFNalpha Responses by Plasmacytoid Dendritic Cells
###end article-title 0
###begin p 1
Conceived and designed the experiments: CGA KJH. Performed the experiments: CGA RJM KEP. Analyzed the data: CGA. Wrote the paper: CGA KJH.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 0 37 <span type="species:ncbi:11048">Lactate dehydrogenase-elevating virus</span>
###xml 39 42 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
###xml 111 114 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
Lactate dehydrogenase-elevating virus (LDV) is a natural infectious agent of mice. Like several other viruses, LDV causes widespread and very rapid but transient activation of both B cells and T cells in lymphoid tissues and the blood. The mechanism of this activation has not been fully described and is the focus of the current studies.
###end p 3
###begin title 4
Principal Findings
###end title 4
###begin p 5
###xml 210 218 202 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 271 278 259 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 430 437 418 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 784 791 764 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 91 94 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 161 165 <span type="species:ncbi:10090">mice</span>
###xml 359 362 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 458 461 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 583 586 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 679 683 <span type="species:ncbi:10090">mice</span>
###xml 843 847 <span type="species:ncbi:10090">mice</span>
###xml 865 869 <span type="species:ncbi:10090">mice</span>
###xml 923 926 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
A known inducer of early lymphocyte activation is IFNalpha, a cytokine strongly induced by LDV infection. Neutralization of IFNalpha in the plasma from infected mice ablated its ability to activate lymphocytes in vitro. Since the primary source of virus-induced IFNalpha in vivo is often plasmacytoid dendritic cells (pDC's), we depleted these cells prior to LDV infection and tested for lymphocyte activation. Depletion of pDC's in vivo eradicated both the LDV-induced IFNalpha response and lymphocyte activation. A primary receptor in pDC's for single stranded RNA viruses such as LDV is the toll-like receptor 7 (TLR7) pattern recognition receptor. Infection of TLR7-knockout mice revealed that both the IFNalpha response and lymphocyte activation were dependent on TLR7 signaling in vivo. Interestingly, virus levels in both TLR7 knockout mice and pDC-depleted mice were indistinguishable from controls indicating that LDV is largely resistant to the systemic IFNalpha response.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 22 25 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 85 88 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
Results indicate that LDV-induced activation of lymphocytes is due to recognition of LDV nucleic acid by TLR7 pattern recognition receptors in pDC's that respond with a lymphocyte-inducing IFNalpha response.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 211 214 211 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Drosten1">[1]</xref>
###xml 216 219 216 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Ksiazek1">[2]</xref>
###xml 221 224 221 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Peiris1">[3]</xref>
###xml 226 229 226 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Plagemann1">[4]</xref>
###xml 439 442 439 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Plagemann2">[5]</xref>
###xml 444 447 444 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Ritzi1">[6]</xref>
###xml 561 564 561 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Riley1">[7]</xref>
###xml 784 787 784 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Onyekaba1">[8]</xref>
###xml 878 881 878 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Plagemann2">[5]</xref>
###xml 883 886 883 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Onyekaba1">[8]</xref>
###xml 888 891 888 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Stueckemann1">[9]</xref>
###xml 893 897 893 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-vandenBroek1">[10]</xref>
###xml 1055 1059 1055 1059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Anderson1">[11]</xref>
###xml 1061 1065 1061 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Contag1">[12]</xref>
###xml 1127 1131 1127 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Marques1">[13]</xref>
###xml 1133 1137 1133 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Notkins1">[14]</xref>
###xml 1139 1143 1139 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Howard1">[15]</xref>
###xml 1145 1149 1145 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Robertson1">[16]</xref>
###xml 1393 1397 1393 1397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Robertson1">[16]</xref>
###xml 1602 1606 1602 1606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Shiow1">[17]</xref>
###xml 1673 1677 1673 1677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-LopezCabrera1">[18]</xref>
###xml 1769 1773 1765 1769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Braun1">[19]</xref>
###xml 1775 1779 1771 1775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Alsharifi1">[20]</xref>
###xml 0 37 <span type="species:ncbi:11048">Lactate dehydrogenase-elevating virus</span>
###xml 39 42 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 267 271 <span type="species:ncbi:10090">mice</span>
###xml 789 792 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 838 843 <span type="species:ncbi:10090">mouse</span>
###xml 947 950 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 1071 1075 <span type="species:ncbi:10090">mice</span>
###xml 1090 1093 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 1195 1198 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
Lactate dehydrogenase-elevating virus (LDV) is a small, positive sense, single stranded RNA virus of the Arteriviridae family, related to coronaviruses such as the severe acute respiratory syndrome (SARS) virus [1], [2], [3], [4]. It is a natural infectious agent of mice that causes very rapid lytic infections generally restricted to a minor subset of non-essential macrophages involved in scavenging extracellular lactate dehydrogenase [5], [6]. The rapid loss of this subset results in the elevated lactate dehydrogenase levels for which the virus is named [7]. Virus titers peak within the first day of infection as susceptible target cells are depleted, and then the infection is maintained at a much lower chronic level dependent on the replenishment of new macrophage targets [8]. LDV establishes chronic infections regardless of mouse strain, age, sex or immune-status [5], [8], [9], [10]. No clinical signs are typically associated with LDV infections, although co-infection with retroviruses can lead to CNS disease under certain circumstances [11], [12], and mice infected with LDV have suppressed immune responses [13], [14], [15], [16]. We recently found that acute infection with LDV induced a state of partial and transient activation in the vast majority of splenic lymphocytes. Activation was characterized by high surface expression of the very early activation marker CD69 [16]. CD69 is the first surface marker known to be upregulated during the activation of lymphocytes and has recently been shown to interact with S1P1 to inhibit the egress of lymphocytes from lymphoid tissues [17]. CD69 expression is upregulated by T cell receptor (TCR) ligation [18] but is not dependent upon it and can be induced by inflammatory cytokines such as IFNalpha [19], [20].
###end p 9
###begin title 10
Results
###end title 10
###begin p 11
###xml 268 272 268 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Robertson1">[16]</xref>
###xml 403 412 403 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006105-g001">Figure 1A</xref>
###xml 492 501 492 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006105-g001">Figure 1B</xref>
###xml 656 665 656 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006105-g001">Figure 1C</xref>
###xml 947 951 947 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Lowenthal1">[21]</xref>
###xml 64 67 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 1008 1011 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
To investigate the mechanism of lymphocyte activation following LDV infection we first analyzed the kinetics of CD69 upregulation on splenic lymphocytes at several time points following infection. CD69 expression was analyzed by flow cytometry as previously described [16] and became detectable at 14 hours post-infection, peaked at 16 to 24 hours, and returned almost to background levels by 72 hours (Figure 1A). The induction of CD69 occurred on CD4+ and CD8+ T cells, as well as B cells (Figure 1B). In addition to the spleen, CD69 upregulation was also observed, albeit to a lesser extent, on lymphocytes from the blood, lymph nodes, and bone marrow (Figure 1C). In contrast, no significant upregulation was observed on lymphocytes from the thymus, which are primarily immature T cells. In contrast to CD69, the IL-2 receptor alpha chain (CD25), which is upregulated later in the activation cascade and is typically dependent on TCR ligation [21], did not increase in expression during the first day of LDV infection (data not shown). This result is consistent with partial rather than full activation of the lymphocytes.
###end p 11
###begin title 12
###xml 0 3 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
LDV-induced upregulation of CD69.
###end title 12
###begin p 13
###xml 470 472 470 472 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 586 587 586 587 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 610 611 610 611 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 640 641 640 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 936 938 936 938 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 228 232 <span type="species:ncbi:10090">mice</span>
###xml 335 338 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 506 510 <span type="species:ncbi:10090">mice</span>
###xml 657 661 <span type="species:ncbi:10090">mice</span>
###xml 684 688 <span type="species:ncbi:10090">mice</span>
###xml 853 856 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 970 973 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
Cells were stained and analyzed by flow cytometry as described (22). (A) Kinetics showing the percentage of splenic lymphocytes with CD69 upregulation. Significant upregulation (P<.05) was observed between 12 and 48hpi (n = 2-4 mice per group per time point). (B) Upregulation of CD69 on major splenic lymphocyte subsets at 16hpi with LDV was analyzed by co-staining with antibodies for CD69 and either CD4, CD8 or CD19 as indicated. The difference in percentage of CD69hi cells between naive and infected mice was statistically significant for all subsets by t test, P = 0.0225 for CD4+ T cells, 0.003 for CD8+ T cells, and 0.0018 for CD19+ B cells (n = 2 mice per naive group and 3 mice per infected group.) (C) Tissue distribution of CD69 upregulation. Lymphocytes from spleen, blood, lymph nodes, bone marrow, and thymus were examined at 16hpi with LDV. All tissues except the thymus showed a significantly higher percentage of CD69hi lymphocytes when infected with LDV infected (P<0.01 for all groups indicated by *).
###end p 13
###begin p 14
###xml 143 147 139 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Isaacs1">[22]</xref>
###xml 186 190 182 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Shiow1">[17]</xref>
###xml 192 196 188 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Braun1">[19]</xref>
###xml 198 202 194 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Alsharifi1">[20]</xref>
###xml 286 290 278 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Robertson1">[16]</xref>
###xml 408 416 396 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 416 420 404 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Braun1">[19]</xref>
###xml 718 726 706 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006105-g002">Figure 2</xref>
###xml 1042 1049 1022 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 256 259 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 463 467 <span type="species:ncbi:10090">mice</span>
###xml 553 557 <span type="species:ncbi:10090">mice</span>
###xml 589 592 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 669 673 <span type="species:ncbi:10090">mice</span>
###xml 965 968 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
The rapid systemic appearance of CD69 expression suggested that a soluble factor such as IFNalpha, a known early responder to viral infections [22] and strong trigger of CD69 expression [17], [19], [20], was inducing the response. To determine whether the LDV-induced IFNalpha response [16] could be responsible for CD69 induction, we first utilized the fact that IFNalpha induces CD69 expression on B cells in vitro[19]. Splenic B cells were isolated from naive mice using CD19+ magnetic beads (Miltenyi Biotec) and cultured with 10% plasma taken from mice infected 16 hours earlier with LDV. B cells cultured for 4 hours with plasma from infected, but not uninfected mice, significantly upregulated CD69 expression (Figure 2). Furthermore, upregulation of CD69 expression was prevented by addition of a neutralizing antibody specific for IFNalpha (PBL Interferon Source) in a concentration-dependent manner. These findings suggested that the IFNalpha response to LDV infection might be responsible for the partial activation of lymphocytes in vivo as well.
###end p 14
###begin title 15
CD69 upregulation in B cells blocked by anti-IFNalpha antibody.
###end title 15
###begin p 16
###xml 149 150 149 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 174 182 174 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 31 34 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
The addition of 10% serum from LDV-infected mice harvested at 16hpi induced upregulation of CD69 in a significant percentage of splenic B cells (2x105 B cells/well) cultured in vitro for 4 hours following their isolation with CD19 magnetic beads (Miltenyi Biotec). Addition of 2 or 20 microl of anti-IFNalpha antibody (PBL Interferon Source) to 198 or 180 microl cultures respectively, significantly reduced the percentage of cells with CD69 upregulation (P</=0.0001 by t test).
###end p 16
###begin p 17
###xml 227 231 223 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-LeBon1">[23]</xref>
###xml 233 237 229 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Cella1">[24]</xref>
###xml 239 243 235 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-AsselinPaturel1">[25]</xref>
###xml 355 359 347 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Cella1">[24]</xref>
###xml 729 733 709 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Krug1">[26]</xref>
###xml 855 864 831 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006105-g003">Figure 3A</xref>
###xml 1179 1188 1147 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006105-g003">Figure 3B</xref>
###xml 1266 1274 1230 1238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1299 1306 1263 1270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1584 1593 1540 1549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006105-g003">Figure 3C</xref>
###xml 1697 1701 1649 1653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Deonarain1">[27]</xref>
###xml 602 605 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 646 650 <span type="species:ncbi:10090">mice</span>
###xml 675 678 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 796 799 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 1010 1014 <span type="species:ncbi:10090">mice</span>
###xml 1161 1166 <span type="species:ncbi:10090">mouse</span>
###xml 1394 1397 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 1474 1478 <span type="species:ncbi:10090">mice</span>
###xml 1531 1534 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 1719 1722 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
Although any cell can produce IFNalpha in response to infection, the acute systemic response to viruses has been attributed to production by plasmacytoid dendritic cells (pDC's, also known as interferon-producing cells or IPC) [23], [24], [25], which comprise only a minor subpopulation of cells but can produce 1000 times as much IFNalpha as other cells [24]. Conventional DC's can also produce high amounts of IFNalpha if they are directly infected, but pDC's are uniquely able to secrete high levels of IFNalpha in response to endocytosed antigen. The role of pDC's in production of IFNalpha during LDV infection was investigated by depleting mice of pDC's the day before LDV infection using a pDC-specific depleting antibody [26]. The plasma IFNalpha response at 16 hours post-infection with LDV, as measured by ELISA, was abolished by pDC depletion (Figure 3A). Thus the systemic IFNalpha response was predominantly due to production by pDC's. In addition to loss of the IFNalpha response in pDC-depleted mice, we also observed the failure of splenic lymphocytes to upregulate CD69. A histogram showing CD69 expression on splenocytes from a representative mouse is shown in Figure 3B. Combined with the dependence on IFNalphafor upregulation of CD69 on B cells in vitro, the data indicate that in vivo upregulation of CD69 on lymphocytes is likely due to the systemic IFNalpha response to LDV infection. Interestingly, the loss of the IFNalpha response in pDC-depleted mice produced no statistically significant difference in LDV plasma levels as measured by real time PCR (15) (Figure 3C). Since IFNalpha can act in both autocrine and paracrine manners to limit virus replication and spread [27], it appears that LDV is quite resistant to the antiviral effects of IFNalpha, even when present at very high systemic levels.
###end p 17
###begin title 18
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
In vivo depletion of plasmacytoid dendritic cells abolishes IFNalpha production.
###end title 18
###begin p 19
###xml 824 825 824 825 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 847 848 847 848 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1125 1129 1125 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Robertson1">[16]</xref>
###xml 1290 1291 1290 1291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1352 1353 1352 1353 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 21 25 <span type="species:ncbi:10090">mice</span>
###xml 136 139 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 221 225 <span type="species:ncbi:10090">mice</span>
###xml 234 237 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
###xml 273 276 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
###xml 392 395 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 565 568 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 612 616 <span type="species:ncbi:10090">mice</span>
###xml 780 783 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 793 797 <span type="species:ncbi:10090">mice</span>
###xml 948 952 <span type="species:ncbi:10090">mice</span>
###xml 1017 1020 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 1140 1143 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 1261 1264 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 1281 1285 <span type="species:ncbi:10090">mice</span>
###xml 1316 1319 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 1343 1347 <span type="species:ncbi:10090">mice</span>
Naive (A.BY x B10)F1 mice were depleted of pDC's by injection of 0.5 mg mPDCA-1 antibody (Miltenyi Biotec) 24 h prior to infection with LDV, and blood samples were collected at 16hpi. (A) Interferon alpha levels in naive mice (left), LDV-infected normal mice (middle), and LDV-infected, pDC-depleted mice (right) were measured by ELISA (PBL Interferon Source). The difference between the two LDV-infected groups was statistically significant by t test (P<0.0001, n = 5). (B) Flow cytometric analysis of peripheral blood lymphocytes showed significant reductions in LDV-induced expression of CD69 in pDC depleted mice (average mean fluorescence intensity of 114.3+/-14.25 vs. 42.96+/-11.85, n = 5, p = 0.0049 by t test). A representative histogram of CD69 expression on cells from LDV-infected mice that were pDC-depleted pDC-) or mock-treated (pDC+) is shown. The histograms of cells from naive animals overlapped with the curves from pDC depleted mice (data not shown). (C) pDC depletion did not significantly alter LDV levels in plasma as indicated by results from semiquantitative real-time RT-PCR as previously described [16]. Relative LDV levels are indicated by real time PCR critical threshold (Ct) values, which were not significantly different between LDV-infected normal mice (pDC+) Ct = 22.05+/-0.33, and LDV-infected, pDC-depleted mice (pDC-) Ct = 21.72+/-0.43 (n = 5).
###end p 19
###begin p 20
###xml 312 316 304 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Kato1">[28]</xref>
###xml 370 374 362 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Butchi1">[29]</xref>
###xml 376 380 368 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Hemmi1">[30]</xref>
###xml 583 595 567 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006105-g004">Figure 4A, B</xref>
###xml 763 772 743 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006105-g004">Figure 4C</xref>
###xml 991 995 971 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-LeThiPhuong1">[31]</xref>
###xml 11 14 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 318 322 <span type="species:ncbi:10090">Mice</span>
###xml 464 467 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 522 526 <span type="species:ncbi:10090">mice</span>
###xml 647 650 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 851 855 <span type="species:ncbi:10090">mice</span>
###xml 870 873 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
Given that LDV is a single-stranded RNA virus, we investigated whether the pDC-dependent IFNalpha response was mediated by toll like receptor 7 (TLR7), which is highly expressed by pDC's, binds to single stranded viral RNA, and is capable of initiating IFNalpha responses in pDC's without their direct infection [28]. Mice containing a genetically inactivated TLR7 gene [29], [30] failed to mount IFNalpha responses or to upregulate CD69 expression in response to LDV infection, whereas genetically matched TLR7 wild type mice showed strong IFNalpha responses and CD69 upregulation (Figure 4A, B). Consistent with the results from pDC depletions, LDV plasma titers were again not significantly different in the absence of TLR7 expression and IFNalpha production (Figure 4C). These results are similar to data from type I interferon receptor-deficient mice infected with LDV, although that study noted slight (two fold) increases in virus titers in the absence of type I interferon signaling [31].
###end p 20
###begin title 21
###xml 0 3 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
LDV-induced CD69 upregulation is TLR7-dependent.
###end title 21
###begin p 22
###xml 187 190 183 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 256 259 252 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 344 347 336 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 359 362 351 354 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 371 374 363 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 436 439 424 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 517 520 505 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 540 541 528 529 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 550 553 538 541 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 572 573 560 561 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 680 684 668 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Robertson1">[16]</xref>
###xml 828 831 816 819 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 858 861 846 849 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 28 32 <span type="species:ncbi:10090">mice</span>
###xml 86 89 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 191 195 <span type="species:ncbi:10090">mice</span>
###xml 260 264 <span type="species:ncbi:10090">mice</span>
###xml 348 352 <span type="species:ncbi:10090">mice</span>
###xml 440 444 <span type="species:ncbi:10090">mice</span>
###xml 609 612 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 777 781 <span type="species:ncbi:10090">mice</span>
###xml 882 886 <span type="species:ncbi:10090">mice</span>
TLR7 wild type and knockout mice on the 129SvEv genetic background were infected with LDV and blood was analyzed at 16hpi. (A) IFNalpha levels in plasma were significantly reduced in TLR7-/- mice as measured by ELISA (PBL Interferon Source). Values in TLR7+/+ mice averaged 795.5 pg/ml while only trace amounts of IFNalpha were detected in TLR7-/- mice ( TLR7+/+ vs. TLR7-/- p = 0.0041 by T test). (B) The low levels of IFNalpha in TLR7-/- mice correlated with reduced percentages of lymphocytes expressing CD69 (TLR7+/+ 57.30%+/-4.15% CD69+ vs. TLR7-/- 4.37%+/-0.28% CD69+, n = 3, p = 0.0002 by t test). (C) LDV-specific semiquantitative real-time RT-PCR as previously described [16] revealed no significant difference in virus levels between TLR7 knockout and TLR7 wild type mice as measured by critical threshold values (TLR7+/+ Ct = 25.93+/-0.59 vs. TLR7-/- 26.90+/-0.38, n = 3 mice/group).
###end p 22
###begin title 23
Discussion
###end title 23
###begin p 24
###xml 485 489 477 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Alsharifi1">[20]</xref>
###xml 554 558 546 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Alsharifi2">[32]</xref>
###xml 696 700 688 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Robertson1">[16]</xref>
###xml 1010 1014 998 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Alsharifi3">[33]</xref>
###xml 1232 1236 1212 1216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006105-Shiow1">[17]</xref>
###xml 166 170 <span type="species:ncbi:10090">mice</span>
###xml 176 179 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 344 347 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 464 484 <span type="species:ncbi:11033">Semliki forest virus</span>
###xml 491 509 <span type="species:ncbi:10515">human adenovirus 2</span>
###xml 511 526 <span type="species:ncbi:11082">West Nile virus</span>
###xml 562 566 <span type="species:ncbi:10090">mice</span>
###xml 691 695 <span type="species:ncbi:10090">mice</span>
Together, our data indicate that pDC's activated in a TLR7-dependent manner are primarily responsible for the rapid systemic IFNalpha response following infection of mice with LDV. Furthermore, the interferon response was most likely responsible for the transient expression of the CD69 very early activation marker on lymphocytes during acute LDV infection. IFNalpha-dependent, partial activation of lymphocytes has also been reported during acute infection with Semliki forest virus [20], human adenovirus 2, West Nile virus, and A/WSN influenza virus [32] in mice. However, not all acute viral infections induce partial activation, as it does not occur in Friend retrovirus infections of mice [16]. Such broad activation is by definition non-specific, and leaves open the question of how it benefits the host. Alsharifi et al. have proposed that IFNalpha-induced partial activation may promote adaptive immune responses by lowering the threshold for full activation once antigen-specific recognition occurs [33]. If so, IFNalpha may be a very important regulatory link between the innate and adaptive immune responses. Based on the findings that CD69 acts downstream of IFNalpha to inhibit lymphocyte egress from lymphoid organs [17], it is also likely that CD69 expression facilitates sustained contacts between lymphocytes and antigen presenting cells during inflammatory responses, thereby enhancing full activation of antigen-specific lymphocytes.
###end p 24
###begin title 25
References
###end title 25
###begin article-title 26
###xml 41 49 <span type="species:ncbi:9606">patients</span>
Identification of a novel coronavirus in patients with severe acute respiratory syndrome.
###end article-title 26
###begin article-title 27
A novel coronavirus associated with severe acute respiratory syndrome.
###end article-title 27
###begin article-title 28
Coronavirus as a possible cause of severe acute respiratory syndrome.
###end article-title 28
###begin article-title 29
###xml 0 37 <span type="species:ncbi:11048">Lactate dehydrogenase-elevating virus</span>
###xml 39 61 <span type="species:ncbi:11047">equine arteritis virus</span>
###xml 67 97 <span type="species:ncbi:38143">simian hemorrhagic fever virus</span>
Lactate dehydrogenase-elevating virus, equine arteritis virus, and simian hemorrhagic fever virus: a new group of positive-strand RNA viruses.
###end article-title 29
###begin article-title 30
###xml 0 37 <span type="species:ncbi:11048">Lactate dehydrogenase-elevating virus</span>
Lactate dehydrogenase-elevating virus: an ideal persistent virus?
###end article-title 30
###begin article-title 31
###xml 15 52 <span type="species:ncbi:11048">lactate dehydrogenase-elevating virus</span>
Replication of lactate dehydrogenase-elevating virus in macrophages. 1. Evidence for cytocidal replication.
###end article-title 31
###begin article-title 32
###xml 61 66 <span type="species:ncbi:10090">Mouse</span>
Transmissible Agent Associated with 26 Types of Experimental Mouse Neoplasms.
###end article-title 32
###begin article-title 33
###xml 24 28 <span type="species:ncbi:10090">mice</span>
###xml 32 69 <span type="species:ncbi:11048">lactate dehydrogenase-elevating virus</span>
Persistent infection of mice by lactate dehydrogenase-elevating virus: effects of immunosuppression on virus replication and antiviral immune responses.
###end article-title 33
###begin article-title 34
###xml 15 52 <span type="species:ncbi:11048">lactate dehydrogenase-elevating virus</span>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
Replication of lactate dehydrogenase-elevating virus in macrophages. 2. Mechanism of persistent infection in mice and cell culture.
###end article-title 34
###begin article-title 35
###xml 0 37 <span type="species:ncbi:11048">Lactate dehydrogenase-elevating virus</span>
###xml 39 42 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 79 82 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
Lactate dehydrogenase-elevating virus (LDV): lifelong coexistence of virus and LDV-specific immunity.
###end article-title 35
###begin article-title 36
###xml 12 16 <span type="species:ncbi:10090">mice</span>
###xml 64 101 <span type="species:ncbi:11048">lactate dehydrogenase-elevating virus</span>
C58 and AKR mice of all ages develop motor neuron disease after lactate dehydrogenase-elevating virus infection but only if antiviral immune responses are blocked by chemical or genetic means or as a result of old age.
###end article-title 36
###begin article-title 37
###xml 22 26 <span type="species:ncbi:10090">mice</span>
###xml 59 96 <span type="species:ncbi:11048">lactate dehydrogenase-elevating virus</span>
Susceptibility of C58 mice to paralytic disease induced by lactate dehydrogenase-elevating virus correlates with increased expression of endogenous retrovirus in motor neurons.
###end article-title 37
###begin article-title 38
B lymphocyte activation by coinfection prevents immune control of friend virus infection.
###end article-title 38
###begin article-title 39
###xml 27 31 <span type="species:ncbi:10090">mice</span>
Infection of tumor-bearing mice with the lactic dehydrogenase agent.
###end article-title 39
###begin article-title 40
###xml 43 47 <span type="species:ncbi:10090">mice</span>
###xml 62 88 <span type="species:ncbi:11048">lactic dehydrogenase virus</span>
Inhibition of cellular immune reactions in mice infected with lactic dehydrogenase virus.
###end article-title 40
###begin article-title 41
###xml 81 118 <span type="species:ncbi:11048">lactate dehydrogenase-elevating virus</span>
Suppression of acute anti-friend virus CD8+ T-cell responses by coinfection with lactate dehydrogenase-elevating virus.
###end article-title 41
###begin article-title 42
CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs.
###end article-title 42
###begin article-title 43
###xml 67 72 <span type="species:ncbi:9606">human</span>
Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors.
###end article-title 43
###begin article-title 44
IFN-alpha/beta enhances BCR-dependent B cell responses.
###end article-title 44
###begin article-title 45
Type I interferons trigger systemic, partial lymphocyte activation in response to viral infection.
###end article-title 45
###begin article-title 46
Regulation of interleukin 2 receptor alpha subunit (Tac or CD25 antigen) gene expression: binding of inducible nuclear proteins to discrete promoter sequences correlates with transcriptional activation.
###end article-title 46
###begin article-title 47
Virus interference. I. The interferon.
###end article-title 47
###begin article-title 48
Links between innate and adaptive immunity via type I interferon.
###end article-title 48
###begin article-title 49
Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon.
###end article-title 49
###begin article-title 50
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology.
###end article-title 50
###begin article-title 51
###xml 30 34 <span type="species:ncbi:10366?0.7619047619047619|species:ncbi:12138?0.0056022408963585435">MCMV</span>
TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function.
###end article-title 51
###begin article-title 52
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Impaired antiviral response and alpha/beta interferon induction in mice lacking beta interferon.
###end article-title 52
###begin article-title 53
Cell type-specific involvement of RIG-I in antiviral response.
###end article-title 53
###begin article-title 54
Analysis of the neuroinflammatory response to TLR7 stimulation in the brain: comparison of multiple TLR7 and/or TLR8 agonists.
###end article-title 54
###begin article-title 55
Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway.
###end article-title 55
###begin article-title 56
###xml 49 53 <span type="species:ncbi:10090">mice</span>
###xml 68 105 <span type="species:ncbi:11048">lactate dehydrogenase-elevating virus</span>
Distinct gamma interferon-production pathways in mice infected with lactate dehydrogenase-elevating virus.
###end article-title 56
###begin article-title 57
Exhaustion of type I interferon response following an acute viral infection.
###end article-title 57
###begin article-title 58
Interferon type I responses in primary and secondary infections.
###end article-title 58
###begin p 59
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 59
###begin p 60
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 60

